The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990: the ESSICS-study pilot project
Department of Medicine III, University of Halle-Wittenberg, Ernst-Grube-Strasse 40, D-06097 Halle, Germany Department of Cardiac Surgery, University of Leipzig, Leipzig, Germany Zentralklinik Bad Berka GmbH, D-09437 Bad Berka, Germany Department of Cardiac Surgery, University of Munich, Munich, Germany Department of Medicine, University of Munich, Munich, Germany Department of Cardiac Surgery, University of Halle-Wittenberg, Ernst-Grube-Strasse 40, D-06097 Halle, GermanyObjective: Cardiac surgery using extracorporeal circulation leads to the release of cytokines and subsequently to a systemic inflammatory response syndrome, which is thought to be a negative prognostic factor for patients’ outcome. A stratification for the risk of an escalating systemic inflammatory response syndrome had been achieved in a monocenter study carried out in 1988–1990, using APACHE II scoring on the morning of the 1st postoperative day. We now re-evaluated this concept prospectively in three independent centers. Methods: The APACHE II based risk stratification was put to test in three independent heart surgery centers in the period from June to December 1996. Nine hundred and forty-five patients after elective cardiac surgery (excluding heart transplantation) with the assistance of the cardiopulmonary bypass were prospectively monitored. Results: We found an increase in mortality with higher APACHE II score values determined on the 1st postoperative day. The mortality rose to nearly 50% with an APACHE II score of ≥28. Patients at high risk for the development of a systemic inflammatory response syndrome (APACHE II score ≥24) significantly differed from patients at lower risk (APACHE II score <19) in the duration of mechanical ventilation and extracorporeal circulation, age and New York Heart Association (NYHA) classification (P<0.05). Conclusion: The APACHE II score determined on the morning of the 1st postoperative day helps identifying the subgroup of patients with escalating systemic inflammatory response syndrome. Comparison with the data obtained in the years 1988–1990, suggests a better prognosis in the current trial for patients at high risk with a similar degree of escalating systemic inflammatory response syndrome.APACHE II scoreCardiopulmonary bypassEscalating systemic inflammatory response syndromeOutcome after cardiac surgeryRisk stratification
Department of Medicine III, University of Halle-Wittenberg, Ernst-Grube-Strasse 40, D-06097 Halle, Germany Department of Cardiac Surgery, University of Leipzig, Leipzig, Germany Zentralklinik Bad Berka GmbH, D-09437 Bad Berka, Germany Department of Cardiac Surgery, University of Munich, Munich, Germany Department of Medicine, University of Munich, Munich, Germany Department of Cardiac Surgery, University of Halle-Wittenberg, Ernst-Grube-Strasse 40, D-06097 Halle, GermanyObjective: Cardiac surgery using extracorporeal circulation leads to the release of cytokines and subsequently to a systemic inflammatory response syndrome, which is thought to be a negative prognostic factor for patients’ outcome. A stratification for the risk of an escalating systemic inflammatory response syndrome had been achieved in a monocenter study carried out in 1988–1990, using APACHE II scoring on the morning of the 1st postoperative day. We now re-evaluated this concept prospectively in three independent centers. Methods: The APACHE II based risk stratification was put to test in three independent heart surgery centers in the period from June to December 1996. Nine hundred and forty-five patients after elective cardiac surgery (excluding heart transplantation) with the assistance of the cardiopulmonary bypass were prospectively monitored. Results: We found an increase in mortality with higher APACHE II score values determined on the 1st postoperative day. The mortality rose to nearly 50% with an APACHE II score of ≥28. Patients at high risk for the development of a systemic inflammatory response syndrome (APACHE II score ≥24) significantly differed from patients at lower risk (APACHE II score <19) in the duration of mechanical ventilation and extracorporeal circulation, age and New York Heart Association (NYHA) classification (P<0.05). Conclusion: The APACHE II score determined on the morning of the 1st postoperative day helps identifying the subgroup of patients with escalating systemic inflammatory response syndrome. Comparison with the data obtained in the years 1988–1990, suggests a better prognosis in the current trial for patients at high risk with a similar degree of escalating systemic inflammatory response syndrome.APACHE II scoreCardiopulmonary bypassEscalating systemic inflammatory response syndromeOutcome after cardiac surgeryRisk stratification
Department of Medicine III, University of Halle-Wittenberg, Ernst-Grube-Strasse 40, D-06097 Halle, Germany Department of Cardiac Surgery, University of Leipzig, Leipzig, Germany Zentralklinik Bad Berka GmbH, D-09437 Bad Berka, Germany Department of Cardiac Surgery, University of Munich, Munich, Germany Department of Medicine, University of Munich, Munich, Germany Department of Cardiac Surgery, University of Halle-Wittenberg, Ernst-Grube-Strasse 40, D-06097 Halle, GermanyObjective: Cardiac surgery using extracorporeal circulation leads to the release of cytokines and subsequently to a systemic inflammatory response syndrome, which is thought to be a negative prognostic factor for patients’ outcome. A stratification for the risk of an escalating systemic inflammatory response syndrome had been achieved in a monocenter study carried out in 1988–1990, using APACHE II scoring on the morning of the 1st postoperative day. We now re-evaluated this concept prospectively in three independent centers. Methods: The APACHE II based risk stratification was put to test in three independent heart surgery centers in the period from June to December 1996. Nine hundred and forty-five patients after elective cardiac surgery (excluding heart transplantation) with the assistance of the cardiopulmonary bypass were prospectively monitored. Results: We found an increase in mortality with higher APACHE II score values determined on the 1st postoperative day. The mortality rose to nearly 50% with an APACHE II score of ≥28. Patients at high risk for the development of a systemic inflammatory response syndrome (APACHE II score ≥24) significantly differed from patients at lower risk (APACHE II score <19) in the duration of mechanical ventilation and extracorporeal circulation, age and New York Heart Association (NYHA) classification (P<0.05). Conclusion: The APACHE II score determined on the morning of the 1st postoperative day helps identifying the subgroup of patients with escalating systemic inflammatory response syndrome. Comparison with the data obtained in the years 1988–1990, suggests a better prognosis in the current trial for patients at high risk with a similar degree of escalating systemic inflammatory response syndrome.APACHE II scoreCardiopulmonary bypassEscalating systemic inflammatory response syndromeOutcome after cardiac surgeryRisk stratification